Delivery Order SPE2DB24D8001-SPE2DB25FLADL
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,913.01 to Dakota Drug, Inc., a small disadvantaged business located in Anoka, Minnesota, for the supply of Mounjaro 2.5 mg/0.5 mL pens. This firm fixed-price delivery order, issued on June 9, 2025, with an ultimate completion date of June 10, 2025, is not set-aside restricted and represents a continuation of DLA's pharmaceutical procurement operations. Dakota Drug, Inc. is performing the work at its Anoka, Minnesota...
- The Defense Logistics Agency awarded a $3,721.20 firm fixed-price delivery order to Dakota Drug, Inc., a small disadvantaged business based in Anoka, Minnesota, for the supply of Mounjaro 5 mg/0.5 mL pen injections. The award was made on June 17, 2025, with an ultimate completion date of June 18, 2025, and carries no set-aside designation. This delivery order is issued under Dakota Drug, Inc.'s larger Indefinite Delivery Contract (SPE2DB24D8001) valued at $999,999,999.00 with DLA Troop Support...
- The Defense Logistics Agency (DLA) awarded a $7,256.28 firm fixed price delivery order to Dakota Drug, Inc., a self-certified small disadvantaged business based in Anoka, Minnesota, for the supply of Mounjaro 7.5 mg/0.5 mL pen injections. The delivery order, issued on July 17, 2025, with an ultimate completion date of July 18, 2025, represents an unrestricted award with no set-aside designation. This delivery order falls under Dakota Drug, Inc.'s larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a delivery order valued at $4,997.29 to Dakota Drug, Inc., a self-certified small disadvantaged business headquartered in Anoka, Minnesota, for the supply of Zepbound 5 mg/0.5 mL pen injectors. This firm fixed-price delivery order was issued on August 8, 2025, with an ultimate completion date of August 11, 2025, and represents part of the company's broader pharmaceutical and medical supply relationship with the federal government. The award carries no...
- The Defense Logistics Agency awarded a $2,032.16 delivery order to Dakota Drug, Inc., a self-certified small disadvantaged business located in Anoka, Minnesota, for the supply of Mounjaro 7.5 mg/0.5 ml pen (0.5 ml) with an ultimate completion date of June 2, 2025. This firm fixed-price delivery order was issued without a set-aside designation and represents a single delivery under Dakota Drug's larger Indefinite Delivery Contract (SPE2DB24D8001) with DLA Troop Support Medical's ECAT Generation V...
- The Defense Logistics Agency awarded a delivery order valued at $1,665.96 to Dakota Drug, Inc., a small disadvantaged business based in Anoka, Minnesota, for the supply of Zepbound 12.5 mg/0.5 mL pen injections. This firm fixed-price delivery order, issued on August 6, 2025, is part of Dakota Drug's larger Indefinite Delivery Contract (SPE2DB24D8001) with DLA Troop Support Medical's ECAT Generation V Program, valued at $999,999,999.00 through December 31, 2025. The contract was awarded without...
- The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed-price delivery order contract valued at $3,351.99 to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the provision of MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. This award is part of Dakota Drug, Inc.'s broader Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999.00, which allows the company to supply a range of pharmaceutical products, medical supplies,...
- The Defense Logistics Agency awarded a $3,790.34 delivery order to Dakota Drug, Inc., a small disadvantaged business based in Anoka, Minnesota, on June 5, 2025, for the supply of Zepbound 12.5 mg/0.5 mL pen injectors. This firm fixed-price delivery order is set to be completed by June 6, 2025, with performance taking place in Anoka, Minnesota. The award carries no set-aside designation and represents a single delivery under Dakota Drug's broader contract vehicle with DLA Troop Support Medical....
- The Defense Logistics Agency awarded a delivery order valued at $2,377.68 to Dakota Drug, Inc. for the supply of Mounjaro 15 mg/0.5 mL pens on July 21, 2025, with completion scheduled for July 22, 2025. This firm fixed price delivery order represents a pharmaceutical supply contract with no set-aside designation. The work will be performed in Anoka, Minnesota, where Dakota Drug, Inc., a self-certified small disadvantaged business, is headquartered. Mounjaro is a diabetes management medication,...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business located in Anoka, Minnesota. The contract is for the delivery of Mounjaro 15 mg/0.5 ml pens, with a ceiling value of $1,033.12 and a period of performance through May 16, 2025. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) identified as SPE2DB24D8001, valued at $999,999,999.00. This IDC is part of the DLA Troop Support...
- SPE2DB24D8001Indefinite Delivery Contract
- SPE2DB24D8001-SPE2DB25FLADLDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,873.31 to Dakota Drug, Inc., a small disadvantaged business based in Anoka, Minnesota, for the supply of Mounjaro 15 mg/0.5 mL pen injections. The contract, issued on August 5, 2025, with an ultimate completion date of August 6, 2025, operates under a firm fixed price structure with no set-aside designation. This delivery order is issued under Dakota Drug's larger Indefinite Delivery Contract (SPE2DB24D8001) with DLA Troop Support Medical's ECAT Generation V Program, valued at $999,999,999.00 and extending through December 31, 2025. The IDC enables the company to provide a comprehensive range of pharmaceutical products, medical supplies, and healthcare equipment to support U.S. Armed Forces medical operations. Dakota Drug, Inc. has established itself as a critical vendor in the federal pharmaceutical supply chain, with a demonstrated track record of delivering diverse medications and medical products to military healthcare facilities. The company's federal portfolio includes diabetes management products, respiratory medications, pain management drugs, cardiovascular medications, and vaccines, positioning it as a strategic supplier for DLA Troop Support Medical's solicitation SPE2DH-21-R-0002, which seeks commercial medical equipment, accessories, and consumables for military medical professionals. As a self-certified small disadvantaged business registered in the System for Award Management since June 2001, Dakota Drug continues to fulfill critical roles in the military medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.9k | 8/5/25 |